What's new

Human medicines European public assessment report (EPAR): MenQuadfi, meningococcal group A, C, W-135 and Y conjugate vaccine, Date of authorisation: 18/11/2020, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): MenQuadfi, meningococcal group A, C, W-135 and Y conjugate vaccine, Date of authorisation: 18/11/2020, Revision: 21, Status: Authorised

Jun 11, 2025 - 15:05
 0
Human medicines European public assessment report (EPAR): MenQuadfi, meningococcal group A, C, W-135 and Y conjugate vaccine, Date of authorisation: 18/11/2020, Revision: 21, Status: Authorised
Human medicines European public assessment report (EPAR): MenQuadfi, meningococcal group A, C, W-135 and Y conjugate vaccine, Date of authorisation: 18/11/2020, Revision: 21, Status: Authorised
Read More

Tags:

Previous Article

STAT+: Pharmalittle: We’re reading about Trump and drug prices, Gilead trial del...

Next Article

Human medicines European public assessment report (EPAR): Bimervax, COVID-19 Vac...

Related Posts

Human medicines European public assessment report (EPAR): Mysimba, naltrexone,bupropion, Date of authorisation: 26/03/2015, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 3, 2025  0

EMA workshop on primary efficacy endpoints for antivirals and monoclonal antibodies intended for the treatment of COVID-19 and influenza, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 5 June 2025, 13:00 (CEST) to 6 June 2025, 17:00 (CEST)

EMA workshop on primary efficacy endpoints for antivira...

May 13, 2025  0

Minutes of the Cancer Medicines Forum - March 2025

May 23, 2025  0